Getinge AB ser. B (GETI-B.ST) Financials
GETI-B.ST Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 56.3 billion | 23.7 billion |
| 2023-12-31 | 55.1 billion | 24.7 billion |
| 2023-09-30 | 53.5 billion | 21.5 billion |
| 2023-06-30 | 52.4 billion | 21.5 billion |
GETI-B.ST Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | 941.0 million | ? |
| 2023-12-31 | 984.0 million | ? |
| 2023-09-30 | 1.1 billion | ? |
| 2023-06-30 | 269.0 million | ? |
GETI-B.ST Net Income
| Date | Net Income |
|---|---|
| 2024-03-31 | 459.0 million |
| 2023-12-31 | 718.0 million |
| 2023-09-30 | 1.3 billion |
| 2023-06-30 | 383.0 million |
GETI-B.ST Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | - | - | 1.8 billion |
| 2023-12-31 | 2.7 billion | - | 1.5 billion |
| 2023-09-30 | 5.3 billion | 6.8 billion | 1.4 billion |
| 2023-06-30 | 4.4 billion | 6.9 billion | 1.4 billion |
GETI-B.ST Shares Outstanding
GETI-B.ST Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 308.0 million | 311.0 million | 2.6 billion | - |
| 2023-12-31 | 340.0 million | 345.0 million | 1.2 billion | 1.5 billion |
| 2023-09-30 | 343.0 million | 281.0 million | 1.1 billion | 1.3 billion |
| 2023-06-30 | 380.0 million | 270.0 million | 1.1 billion | 1.3 billion |
GETI-B.ST Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 7.5 billion | 3.9 billion |
| 2023-12-31 | 9.9 billion | 5.9 billion |
| 2023-09-30 | 7.6 billion | 4.0 billion |
| 2023-06-30 | 7.2 billion | 4.1 billion |
GETI-B.ST
Price: SEK185.50
Dividend Yield: 0.02%
Forward Dividend Yield: 2.37%
Payout Ratio: 49.72%
Dividend Per Share: 4.40 SEK
Earnings Per Share: 8.39 SEK
P/E Ratio: 23.57
Exchange: STO
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 57.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 30.00%
DGR5: 30.00%
DGR10: 13.03%
DGR20: 14.11%